Johnson and Johnson Innovative Medicine
Phase 3Explore how Johnson & Johnson Innovative Medicine applies rigorous science and patient-centered innovation to transform healthcare—with breakthrough treatments in oncology, immunology, neuroscience and beyond.
Founded
2023
Focus
AntibodiesBiologicsSmall Molecules
About
Explore how Johnson & Johnson Innovative Medicine applies rigorous science and patient-centered innovation to transform healthcare—with breakthrough treatments in oncology, immunology, neuroscience and beyond.
Company Info
TypePrivate
Founded2023
LocationBeerse, Belgium
StagePhase 3
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile